This time it was Bucharest, the capital of Romania that hosted the HepHIV Conference 2019. Romania holds the EU presidency in the first half of 2019, and faces challenges in responding to the HIV, TB and viral hepatitis epidemics, in particular when it comes to addressing and including key...
We know what works. Opioid substitution therapy in prisons, safe needles in the streets, direct-acting antivirals (DAAs) for anyone who’s infected. No, what we need to eliminate hepatitis C isn’t more interventions. What we need is the political will to...
The aim of this document is to show an approach based on the opportunities that harm reduction offers to people who use drugs, to the community and to society. It is part of the HA-REACT Joint Action on HIV and Co-infection Prevention and Harm Reduction.
AIDS Action Europe Member and Partner Meeting took place on Saturday, October 20, in Berlin. This year the AAE Steering Committee decided to focus on 2 topics of concern for civil society organisations working in the field: good practices and gaps in addressing women in harm reduction and the...
This video explains what harm reduction is and how it benefits people who use drugs, as well as their families and communities.
Harm reduction acknowledges that people should not need to stop using drugs to receive help. Research shows that harm reduction decreases the negative effects...
